4/A

PRIMARY DOCUMENT

Company: LIGAND PHARMACEUTICALS INC
Filed: March 3, 2011
Period of Report: February 24, 2011
Accession Number: 0000886163-11-000025

View Document ↗ View on SEC.gov ↗